Select Page

Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada

by | Jul 21, 2026 | Business, JPost Biztech | 0 comments

D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections. | Read More in JPost.com – Business & Innovation | The Jerusalem Post